DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 3 filers reported holding DIPLOMAT PHARMACY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 170 | +178.7% | 0.00% | – |
| Q1 2019 | $0 | – | 61 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 61 | -87.3% | 0.00% | -100.0% |
| Q3 2018 | $8,000 | -33.3% | 479 | -7.2% | 0.00% | -50.0% |
| Q2 2018 | $12,000 | +50.0% | 516 | -12.5% | 0.00% | +33.3% |
| Q1 2018 | $8,000 | 0.0% | 590 | +41.1% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | -27.3% | 418 | -25.8% | 0.00% | -40.0% |
| Q3 2017 | $11,000 | +37.5% | 563 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $8,000 | +300.0% | 563 | +288.3% | 0.00% | +300.0% |
| Q1 2017 | $2,000 | +100.0% | 145 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | -75.0% | 145 | 0.0% | 0.00% | -66.7% |
| Q3 2016 | $4,000 | +33.3% | 145 | +52.6% | 0.00% | +50.0% |
| Q2 2016 | $3,000 | +50.0% | 95 | -7.8% | 0.00% | +100.0% |
| Q1 2016 | $2,000 | -77.8% | 103 | -64.2% | 0.00% | -83.3% |
| Q4 2015 | $9,000 | – | 288 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |